pathway

Camp Signaling

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Camp Signaling: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

158Connections

0Hypotheses

0Analyses

13Outgoing

50Incoming

0Experiments

0Debates

No summary available yet. View on Wiki →

No AI portrait yet

🔀 Pathway Info

Name	Camp Signaling
Key Genes/Proteins	ACHE, actn2, ACTN2, AGING, Akt, AKT
Related Diseases	Aging, Als, ALS, Alzheimer, Anxiety

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

cAMP Signaling Pathway in Neurodegeneration

mechanism · 1157 words

→

Pathway Diagram

graph TD
    Als["Als"] -->|"therapeutic target"| Camp_Signaling["Camp Signaling"]
    RGS6["RGS6"] -.->|"inhibits"| Camp_Signaling["Camp Signaling"]
    AKT["AKT"] -->|"protects against"| Camp_Signaling["Camp Signaling"]
    PI3K["PI3K"] -->|"protects against"| Camp_Signaling["Camp Signaling"]
    style Camp_Signaling fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (13)

Target	Relation	Type	Str
dopamine neuron survival	promotes	process	0.90
SNCA Expression	downregulates	process	0.85
Parkinson's Disease	protects_against	disease	0.80
senescence	modulates	process	0.75
MAPK SIGNALING	protects_against	concept	0.50
DOPAMINE	inhibits	concept	0.50
MAPT	associated_with	gene	0.45
CLU	associated_with	gene	0.45
DOPAMINE	associated_with	phenotype	0.45
NEURONS	associated_with	cell_type	0.45
NEURON	associated_with	cell_type	0.45
PI3K	associated_with	gene	0.45
MAPK	associated_with	gene	0.45

Incoming (145)

Source	Relation	Type	Str
RGS6	upregulates	gene	0.90
D2 AUTORECEPTOR	regulates	receptor	0.85
Als	therapeutic_target	disease	0.65
PARKINSON	therapeutic_target	gene	0.60
NEURODEGENERATIVE DISEASES	associated_with	gene	0.60
FERROPTOSIS	therapeutic_target	gene	0.60
Parkinson	therapeutic_target	disease	0.60
MAPK	protects_against	gene	0.60
AND	protects_against	gene	0.60
HUB GENES	associated_with	gene	0.60
NEURON	inhibits	gene	0.60
PARKINSON	inhibits	gene	0.60
NEURODEGENERATION	inhibits	gene	0.60
APOPTOSIS	inhibits	gene	0.60
STROKE	inhibits	gene	0.60
RGS6	inhibits	gene	0.60
AKT	protects_against	gene	0.60
PI3K	protects_against	gene	0.60
OXIDATIVE STRESS	therapeutic_target	gene	0.60
PARKINSON'S DISEASE	therapeutic_target	gene	0.60
ERK1	treats	gene	0.60
RAF1	treats	gene	0.60
ANXIETY	treats	gene	0.60
BDNF	treats	gene	0.60
CREB1	treats	gene	0.60
DEPRESSION	therapeutic_target	gene	0.60
SYNAPSE	therapeutic_target	gene	0.60
Anxiety	treats	disease	0.60
Depression	therapeutic_target	disease	0.60
IDH1	therapeutic_target	gene	0.60
KCNQ1	therapeutic_target	gene	0.60
DRD2	therapeutic_target	gene	0.60
IDH2	therapeutic_target	gene	0.60
SCN5A	therapeutic_target	gene	0.60
SYNAPSE	interacts_with	gene	0.60
LMNA	therapeutic_target	gene	0.60
PPARG	therapeutic_target	gene	0.60
TNF	therapeutic_target	gene	0.60
KCNH2	therapeutic_target	gene	0.60
AND	inhibits	gene	0.60
GAPDH	associated_with	gene	0.60
AKT1	associated_with	gene	0.60
AGING	associated_with	gene	0.60
GENES	associated_with	gene	0.60
TP53	associated_with	gene	0.60
CREB	inhibits	gene	0.60
APOPTOSIS	regulates	gene	0.60
APP/PS1	inhibits	gene	0.60
BDNF	inhibits	gene	0.60
ALZHEIMER	inhibits	gene	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity